To further clarify whether METTL3 plays a key role in SCLC chemoresistance, qRT–PCR and Western blotting were used to analyse METTL3 expression in two pairs of chemotherapy drug-sensitive and -resistant cell lines (H69 and H69AR; H446 and H446DDP). The gene discussed is METTL3; the disease is small cell lung carcinoma.